Related Experiment Video
Updated: Jan 29, 2026

Reproductive Techniques for Ovarian Monitoring and Control in Amphibians
Published on: May 12, 2019
Ovarian stimulation protocols in assisted reproductive technology: an update
Colin M Howles1,2, Diego Ezcurra1, Roy Homburg3
1a Merck Serono S.A. - Geneva , Geneva, Switzerland.
Controlled ovarian stimulation (COS) uses gonadotropins to improve egg quality for assisted reproduction. Individualized protocols and anti-Müllerian hormone levels enhance success, but strategies for poor responders are still needed.
Area of Science:
- Reproductive Endocrinology
- Assisted Reproductive Technology
Background:
- Controlled ovarian stimulation (COS) is crucial for assisted reproductive technology (ART), aiming for multiple follicle development and high-quality oocytes.
- Recombinant human follicle-stimulating hormone (r-hFSH) is the current standard for COS, with new formulations including long-acting r-hFSH and combined r-hFSH/luteinizing hormone (LH) available.
- Urinary FSH formulations, with or without LH activity, also exist as treatment options.
Purpose of the Study:
- To review current advancements in controlled ovarian stimulation (COS) protocols for assisted reproductive technology.
- To highlight the importance of individualized COS protocols for optimizing efficacy and safety, focusing on singleton pregnancies and minimizing ovarian hyperstimulation syndrome.
- To discuss the role of biomarkers like anti-Müllerian hormone (AMH) in predicting ovarian response and the ongoing need for strategies for poor responders.
Main Methods:
- Review of current gonadotropin preparations used in controlled ovarian stimulation (COS).
- Discussion of individualized COS protocols based on ovarian response estimation using antral follicle count and anti-Müllerian hormone (AMH) levels.
- Exploration of emerging trends and future expectations in ART, including biomarker development.
Main Results:
- Individualized COS protocols, guided by ovarian response markers like AMH, improve treatment efficacy and safety.
- Newer formulations of gonadotropins, including long-acting r-hFSH and combined r-hFSH/LH, offer enhanced treatment options.
- Anti-Müllerian hormone (AMH) is identified as the most reliable single marker for estimating ovarian response.
Conclusions:
- Current COS protocols allow for personalization to maximize singleton pregnancy rates while minimizing OHSS risk.
- While AMH is a key marker, effective management strategies for poor responders to COS remain an area requiring further research.
- Future developments in biomarkers and techniques are anticipated to further refine oocyte and embryo selection and assess uterine receptivity.
More Related Videos
11:29Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
Published on: January 22, 2022
11:26Home-Based Transcranial Direct Current Stimulation Device Development: An Updated Protocol Used at Home in Healthy Subjects and Fibromyalgia Patients
Published on: July 14, 2018
Related Concept Videos
Reproductive Cloning
Somatic Cell Nuclear Transfer
In SCNT, an egg cell is taken from an animal and its nucleus is removed, creating an enucleated egg. Then a somatic...
Asexual Reproduction
Overview of the Reproductive System
The gonads, or primary reproductive organs, produce gametes and sex hormones. In males, the testes produce spermatozoa and testosterone, which is responsible for developing secondary male sex characteristics, including a deeper voice, larger muscles, facial and body...
Disorders of the Female Reproductive System
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Ovarian Cycle